Publications
ShareCompartir
- Morbidity and Mortality Weekly Report (MMWR)
- Emerging Infectious Diseases (EID)
- Other References
- Other Sources
Morbidity and Mortality Weekly Report (MMWR)
- Kaplan JE, Benson C, Brooks JT, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207. (Leishmaniasis chapter found on pages 99-103.)
- Two cases of visceral leishmaniasis in U.S. military personnel—Afghanistan, 2002–2004 (April 2, 2004 / 53(12);265-268)
- Update: cutaneous leishmaniasis in U.S. military personnel—Southwest/Central Asia, 2002–2004 (April 2, 2004 / 53(12);264-265)
- Cutaneous leishmaniasis in U.S. military personnel—Southwest/Central Asia, 2002–2003(October 24, 2003 / 52(42);1009-1012)
- Unexplained illness among Persian Gulf War veterans in an Air National Guard Unit: preliminary report — August 1990-March 1995 (June 16, 1995 / 44(23);443-447)
- Viscerotropic leishmaniasis in persons returning from Operation Desert Storm — 1990 – 1991 (February 28, 1992 / 41(08);131-134)
Emerging Infectious Diseases (EID)
- Cojean S, Houzé S, Haouchine D, et al. Leishmania resistance to miltefosine related to genetic marker [letter]. Emerg Infect Dis 2012;18:704-6.
- Barrio A, Parodi CM, Locatelli F, et al. Leishmania infantum and human visceral leishmaniasis, Argentina [letter]. Emerg Infect Dis 2012;18:354-5.
- Nerlich AG, Bianucci R, Trisciuoglio A, et al. Visceral leishmaniasis during Italian Renaissance, 1522–1562. Emerg Infect Dis 2012;18:184-6.
- Costa CH, de Miranda-Santos IK. Aircraft and risk of importing a new vector of visceral leishmaniasis [letter]. Emerg Infect Dis 2011;17:1333-4.
- Saha S, Goswami R, Pramanik N, et al. Easy test for visceral leishmaniasis and post-kala-azar dermal leishmaniasis. Emerg Infect Dis 2011;17:1304-6.
- Cascio A, Iaria C. Appropriate screening for leishmaniasis before immunosuppressive treatments [letter]. Emerg Infect Dis 2009;15:1706.
- Schriefer A, Guimaraes LH, Machado PR, et al. Geographic clustering of leishmaniasis in northeastern Brazil. Emerg Infect Dis 2009;15:871-6.
- Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV. Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerg Infect Dis 2009;15:956-9.
- Antoniou M, Messaritakis I, Christodoulou V, et al. Increasing incidence of zoonotic visceral leishmaniasis on Crete, Greece. Emerg Infect Dis 2009;15:932-4.
- Rojas E, Parrado R, Delgado R, Reithinger R, Garcia AL. Leishmaniasis in Chaparé, Bolivia [letter]. Emerg Infect Dis 2009;15:678-80.
- Singer SR, Abramson N, Shoob H, Zaken O, Zentner G, Stein-Zamir C. Ecoepidemiology of cutaneous leishmaniasis outbreak, Israel. Emerg Infect Dis 2008;14:1424-6.
- Rhajaoui M, Nasereddin A, Fellah H, et al. New clinico-epidemiologic profile of cutaneous leishmaniasis, Morocco. Emerg Infect Dis 2007;13:1358-60.
- Gangneux JP, Sauzet S, Donnard S, et al. Recurrent American cutaneous leishmaniasis [letter]. Emerg Infect Dis 2007;13:1436-8.
- Nawaratna SS, Weilgama DJ, Wijekoon CJ, Dissanayake M, Rajapaksha K. Cutaneous leishmaniasis, Sri Lanka. Emerg Infect Dis 2007;13:1068-70.
- Siriwardana HV, Noyes HA, Beeching NJ, Chance ML, Karunaweera ND, Bates PA. Leishmania donovani and cutaneous leishmaniasis, Sri Lanka. Emerg Infect Dis 2007;13:476-8.
- Faulde MK, Heyl G, Amirih ML. Zoonotic cutaneous leishmaniasis, Afghanistan [letter]. Emerg Infect Dis 2006;12:1623-4.
- Zink AR, Spigelman M, Schraut B, Greenblatt CL, Nerlich AG, Donoghue HD. Leishmaniasis in ancient Egypt and Upper Nubia [letter]. Emerg Infect Dis 2006;12:1616-7.
- Malik AN, John L, Bryceson AD, Lockwood DN. Changing pattern of visceral leishmaniasis, United Kingdom, 1985–2004. Emerg Infect Dis 2006;12:1257-9.
- Rotureau B, Joubert M, Clyti E, Djossou F, Carme B. Leishmaniasis among gold miners, French Guiana. Emerg Infect Dis 2006;12:1169-70.
- Boehme CC, Hain U, Novosel A, Eichenlaub S, Fleischmann E, Loscher T. Congenital visceral leishmaniasis [letter]. Emerg Infect Dis 2006;12:359-60.
- Duprey ZH, Steurer FJ, Rooney JA, et al. Canine visceral leishmaniasis, United States and Canada, 2000–2003. Emerg Infect Dis 2006;12:440-6.
- Reithinger R, Aadil K, Kolaczinski J, Mohsen M, Hami S. Social impact of leishmaniasis, Afghanistan. Emerg Infect Dis 2005;11:634-6.
- Brooker S, Mohammed N, Adil K, et al. Leishmaniasis in refugee and local Pakistani populations. Emerg Infect Dis 2004;10:1681-4.
- Reithinger R, Aadil K, Hami S, Kolaczinski J. Cutaneous leishmaniasis, northern Afghanistan. Emerg Infect Dis 2004;10:966-7.
- King RJ, Campbell-Lendrum DH, Davies CR. Predicting geographic variation in cutaneous leishmaniasis, Colombia. Emerg Infect Dis 2004;10:598-607.
- Gradoni L, Gramiccia M, Scalone A. Visceral leishmaniasis treatment, Italy. Emerg Infect Dis 2003;9:1617-20.
- Harms G, Schonian G, Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis 2003;9:872-5.
- Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, Coleman PG. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis 2003;9:727-9.
- Adini I, Ephros M, Chen J, Jaffe CL. Asymptomatic visceral leishmaniasis, northern Israel. Emerg Infect Dis 2003;9:397-8.
- Franke CR, Ziller M, Staubach C, Latif M. Impact of the El Niño/Southern Oscillation on visceral leishmaniasis, Brazil. Emerg Infect Dis 2002;8:914-7.
- Arias JR, Monteiro PS, Zicker F. The reemergence of visceral leishmaniasis in Brazil. Emerg Infect Dis 1996;2:145-6.
Other References
-
Aronson, N., Herwaldt, B.,et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2016: 10.1093/cid/ciw670
- Clarke CF, Bradley KK, Wright JH, Glowicz J. Emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma. Am J Trop Med Hyg 2013;88:157-61.
- Murray HW. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 2012;86:434-40.
- Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
- Jirmanus L, Glesby MJ, Guimaraes LH, et al. Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period. Am J Trop Med Hyg 2012;86:426-33.
- de Almeida ME, Steurer FJ, Koru O, Herwaldt BL, Pieniazek NJ, da Silva AJ. Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2. J Clin Microbiol 2011;49:3143-9.
- WHO. Control of the leishmaniases. World Health Organization technical report series 2010:xii-xiii, 1–186, back cover.
- Gonzalez U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev 2009; CD004834.
- Gonzalez U, Pinart M, Reveiz L, Alvar J. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008; CD005067.
- Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of New World cutaneous leishmaniasis: a systematic review with a meta-analysis. Int J Dermatol 2008;47:109-24.
- Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008;2:e313.
- Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Neto VA. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 2007;77:266-74.
- Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007;7:581-96.
- Cruz A, Rainey PM, Herwaldt BL, Stagni G, Palacios R, Trujillo R, Saravia NG. Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. J Infect Dis 2007;195:602-8.
- Alvar J, Croft SL, Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 2006;61:227-79.
- Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol 2006;22:552-7.
- Bern C, Adler-Moore J, Berenguer J, et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006;43:917-24.
- Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005;366:1561-77.
Other Sources
- Herwaldt BL. Protozoa and helminths. In Fleming DO, Hunt DL (eds.). Biological Safety: Principles and Practices. 4th ed. Washington, DC: American Society for Microbiology, 2006:115-61.
- Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microb Rev 2001;14:659-88.
- Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
- Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.
- Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996;14:417-23.
- Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 1993;118:779-84.
- Page last reviewed: December 1, 2016
- Page last updated: December 7, 2016
- Content source: